Your browser doesn't support javascript.
loading
Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
Novitzky-Basso, Igor; Lam, Wilson; Chiarello, Caden; Pasic, Ivan; Law, Arjun D; Michelis, Fotios V; Gerbitz, Armin; Viswabandya, Auro; Lipton, Jeffrey H; Kumar, Rajat; Mattsson, Jonas; Messner, Hans A; Marras, Theodore K; Mittoo, Shikha; Kim, Dennis Dong Hwan.
Afiliação
  • Novitzky-Basso I; Messner Allogeneic Blood and Marrow Transplantation Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Lam W; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Chiarello C; Messner Allogeneic Blood and Marrow Transplantation Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Pasic I; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Law AD; Messner Allogeneic Blood and Marrow Transplantation Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Michelis FV; Messner Allogeneic Blood and Marrow Transplantation Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Gerbitz A; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Viswabandya A; Messner Allogeneic Blood and Marrow Transplantation Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Lipton JH; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Kumar R; Messner Allogeneic Blood and Marrow Transplantation Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Mattsson J; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Messner HA; Messner Allogeneic Blood and Marrow Transplantation Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Marras TK; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Mittoo S; Messner Allogeneic Blood and Marrow Transplantation Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Kim DDH; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Eur J Haematol ; 111(5): 687-696, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37491877

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article